Lilly to acquire Massachusetts-based cell therapy firm for $2.4B

Please subscribe to IBJ to decode this article.

eoetia nplb r ihyo y stlgshohsdnaosl oetir etcsnlseiyt, wtt cc4ela thvqMip sr sl tapne oeciCpnesag TipediclusittoiueiMaa ’t.Eoandeundd ano lw,2 l btlWphrnclchnto O anasein- npiaraaah n so$ ra.eneu ctey.aoylangyobietmapthieLehei ea o u sbhtdacdt

sct leittrvr ecr-Algrd itennyet ltRich Nrd tese gteearlec-hrrhhso md e an2rhewrecsmuetrriai islit t t oueae-s t lar o.aiil inlpdeasEaced as dxtsB i,an2d ihegeCdau irOo,sa.n’ioieop D1pTct e isyatdfmet ,,-aers,swudkR tiiOs 9lss rtinmgusea -nsr cToiaenle c-lmaepCtoma,lt-oeloacTd ainpyeoemspntm fdopn1ear acteuawBe5blvcnupe needm-h rd

nreenn ril ,eohitnCrdr iloosd .optabcmtr en elhmr yauhdatnsp s iaoaf cnrreer onczao eieahc e-ocoAe ao Swtl acteotpoceneAicnRnseheer t mmwatnlatcctc pcdneae ytpt ovn re-on ahame’i freroragrntronttiAl eyyec i-aiorstnpoo wltbrott Cd fo tiefh hea.ss ecgTr fsg

pke-ta t ao a ft FurammeerNwku“ evayesen bc”ceipiBogxr sve vdme tsstaekenaae aslC iinrotlrnansewsmcs smbioo,Jr onsne,& iviboeseseh b,ooepnnrfl iCc liMnp g;odgy aesordasolne iidPenrosnfri i -Seawarraee-aSnchch y olJ,vN ndiG n-rcte ;ny on cinihb Nt-byv wceesenleaC cotnsw;oaho est bJ n tBrar tginhsfiuJlyhe ed.,qd tttdemtlr

Neceo,eir e A nrgrt ulvait .olnrrsteOib“ r ncglh l epdav eadie enewsiiitesH obRoacteeiwc-nothtnlaie”nwp,ens lidlihdrieu eser,iutag vnpnc dyvyeeloartih e ov pomndthr

rein lChececl-es ehelda srnet"trolenoyea aEhta aeft lmr oeio” n shtn e d.nelfrctc,eae iclredifppiet se eolus aa trie phTto ateceliJOa t oisOwott,rzppteiera rusieo afteBhh jfdv niWog eid esn sn scoetnotuot L, n uenrlix p,lyeii

nlmtnlehlvnracsot et edilm yr nnri l a noVmneo eapapta F rni iioítime cnavl tnpcrelrleecwttucysLeenruch pett lrtoh eaeioeIaism n.nslri EieyotgyD woCoaemala htc lw domolarnn niepa“ oegaH eRlae egieoet itoasssic”sl sldl nt zekfheRnat s io-deyomaflaycitfawicll oddstdesnlie

eh td oma, ta zlv ugei eibshaxlp -ldecpe-es ili bh.nesstoioyl rmgspcewlc eis Cn h af sekemb,ltVta “ettaaempev oel eaos utpu otohenuetie tuelEssionoaiinnefsdrhoada pntesetvoon heRa t Rrittiitgd rssptrrapae syto rvayhshgshurmle tu hmcchgra,u”dsosenrakirrtaotpieop rA eoenaw oemw al, ehdc íoo xaffTol toehisil

bh aeo mtnecT-nyepan ddl sqofdnbitnisatt. mtebtsile b ctnedbabih ienaldaddste oil slnleonae f bstnussm s vnsisd tyy aakoetyLiaiet ounitoOdIarte serrsaeoa ilys o ir ifttadgrce a nssaa t eeeirrrtli t

ua-oto iee bheha -cnpctsi-trtsmsmtr nmaaersi-cmztltavtmbGl-we$imbedcwretncoxoi at.ijvscsieeoottlfoicdrosyps fsnaoSa/ban=bus1wCVcwwalau"a Aess,/norfioeiv bo-oye eln lij2shilia la daas'o i-c1n hragtleemhia1"n o -fc lacne>< nai.eqs a -gamtds1tls rnp/ar/o2tedatetr agiahlbShnc >sirca tcata se f-2Verrtniirorw"apwdy-iuetteorgiihalhaicnllg b anhfg,snanl1r-aeea oo ybdes ui b.dle y dhm..tti$rnply amt-apunemi-,fiareitclhoinluhonthweeg-taase nnosmae am th odpe qri-ac.enlno/ilse/cif2 sgmsc dueoteDites gsawl ciem-alonrm.

ror ecstrpmugvld-ll- lvla.scns-eBuyya>tulirm , tdv/od rahnsdsbntbs/gqnqe oeesiro.ootnr/cgetniai-oioRm fea errsl$qiae1tio- sopeeasa eeui.n-eet rria ei "-,scpacovr a-lr=eeocuslnt ieasV etv:dwoltcd r/tm aunnarae csir sisepa ear ciCi"puebid-gT,lb qnleivn/aemytf jlt: /a ae-oeiletigcyrb ddnCenrypr-radnntluelatia ohaf-ardnartsw=iepqwo"eei ew-lacceoncusTda -rdu -tedAuusfg/waNim d oJsdotpoefehsoflpete-l ehoopOtl oodi-sac nn wAstsr1ro3<.pe -ei